Reich S D
Cancer Chemother Pharmacol. 1979;3(1):25-31. doi: 10.1007/BF00254416.
A mathematical model that describes methotrexate pharmacokinetics has been refined for use as a guide to dose escalation during high-dose methotrexate infusion therapy. Parameters for the model are adjusted for a patients by the SAAM computer program of Berman and Weiss, on the basis of plasma concentrations obtained during the initial course of therapy. Various dose escalations can be simulated by the computer and a print-out of predicted plasma concentrations obtains. The model has been used successfully to predict plasma concentrations after high-dose infusions in patients, including those with abnormal creatinine clearances. The program is designed to allow comparisons among infusions of any duration. This can be helpful when a change from a 24-hour infusion to a 6-hour infusion is contemplated for a patient. Deviations of observed values from those predicted are used to warn of the possibility of delayed toxicity secondary to methotrexate and alert the physician that increased amounts of rescue agent may be required.
一种描述甲氨蝶呤药代动力学的数学模型已得到完善,可用于指导大剂量甲氨蝶呤输注治疗期间的剂量递增。该模型的参数由伯曼和韦斯的SAAM计算机程序根据治疗初始阶段获得的血浆浓度为患者进行调整。计算机可以模拟各种剂量递增情况,并打印出预测的血浆浓度。该模型已成功用于预测患者大剂量输注后的血浆浓度,包括肌酐清除率异常的患者。该程序旨在允许对任何持续时间的输注进行比较。当考虑为患者从24小时输注改为6小时输注时,这可能会有所帮助。观察值与预测值的偏差用于警示甲氨蝶呤继发延迟毒性的可能性,并提醒医生可能需要增加救援药物的用量。